Effects of ethyl-icosapentate on renal function in patients with chronic kidney disease
Not Applicable
- Conditions
- Chronic kidney disease with hyperlipidemia
- Registration Number
- JPRN-UMIN000008619
- Lead Sponsor
- Department of Internal Medicine, Division of Nephrology, Juntendo University Faculty of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients who are easy to bleed. 2. Patients treated with ethyl icosapentate at the time of study initiation. 3. Patients who are judged as ineligible by clinical physicians.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum lipid: (F) LDL, HDL, (F) LDL/HDL ratio, total cholesterol, Triglyceride Renal function: proteinuria(albuminurina), serum Creatinine , eGFR(estimated Glomerular Filtration Rate) , serum cystatin C, Urinary Liver-Type Fatty Acid Binding Protein, Fraction of serum fatty acids(EPA/AA ratio)
- Secondary Outcome Measures
Name Time Method high sensitivity CRP, RLP-C,VLDL apolipoprotein(A1,B,E),8-OHDG